Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Krystal Biotech, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
KRYS
Nasdaq
2834
www.krystalbio.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Krystal Biotech, Inc.
Strength Seen in Ginkgo Bioworks (DNA): Can Its 14.5% Jump Turn into More Strength?
- Feb 6th, 2025 1:24 pm
Krystal Biotech to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025
- Feb 6th, 2025 1:00 pm
Is the Options Market Predicting a Spike in Krystal Biotech (KRYS) Stock?
- Jan 24th, 2025 2:36 pm
US Growth Companies With High Insider Ownership In January 2025
- Jan 22nd, 2025 11:05 am
High Growth Tech Stocks to Watch in January 2025
- Jan 21st, 2025 6:05 pm
Jeune Aesthetics Appoints Nishant Saxena as Chief Financial Officer
- Jan 14th, 2025 1:00 pm
3 US Growth Stocks With Insider Ownership Expecting Up To 85% Earnings Growth
- Dec 24th, 2024 3:01 pm
Krystal Biotech, Inc. (NASDAQ:KRYS) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
- Dec 23rd, 2024 11:40 am
KRYS Reports Upbeat Initial Data From Lung Cancer Study of KB707
- Dec 19th, 2024 4:08 pm
Krystal Biotech Says Initial Results From Kyanite-1 Trial Show 'Early Evidence' of Monotherapy Activity
- Dec 18th, 2024 2:23 pm
Krystal Biotech Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients with Advanced Non-Small Cell Lung Cancer
- Dec 18th, 2024 1:00 pm
KRYS Stock Down on Initial Clinical Updates on KB407 & KB408
- Dec 13th, 2024 4:08 pm
Krystal Biotech announces initial update for KB408, KB407
- Dec 13th, 2024 1:20 pm
Why Is Prothena (PRTA) Down 17.9% Since Last Earnings Report?
- Dec 12th, 2024 4:30 pm
Krystal Biotech Announces Initial Clinical Update for Rare Respiratory Disease Programs KB408 and KB407 Including Early Clinical Evidence of Gene Delivery to the Lung of AATD Patients and Increase in Lung AAT to Therapeutic Levels
- Dec 12th, 2024 1:00 pm
Krystal Biotech Provides Update on EMA’s Ongoing Regulatory Review of B-VEC for Dystrophic Epidermolysis Bullosa
- Dec 9th, 2024 9:15 pm
Why Is CRISPR Therapeutics (CRSP) Up 0.8% Since Last Earnings Report?
- Dec 5th, 2024 4:30 pm
Why Is Krystal Biotech (KRYS) Up 6.6% Since Last Earnings Report?
- Dec 4th, 2024 4:30 pm
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
- Nov 29th, 2024 2:50 pm
Krystal Biotech to Present at Upcoming Investor Conferences
- Nov 27th, 2024 12:00 pm
Scroll